{"blog_url":"https://uneyama.hatenadiary.jp/","width":"100%","author_name":"uneyama","blog_title":"\u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b","author_url":"https://blog.hatena.ne.jp/uneyama/","type":"rich","image_url":null,"description":"HMD Strategies for Ensuring Diversity, Inclusion, and Meaningful Participation in Clinical Trials: Proceedings of a Workshop August 26, 2016 http://nationalacademies.org/hmd/Reports/2016/strategies-for-ensuring-diversity-inclusion-meaningful-participation-in-clinical-trials-proceedings.aspx \u7c73\u56fd\u306e\u4eba\u3005\u306e\u591a\u69d8\u2026","height":"190","categories":["NAS"],"provider_url":"https://hatena.blog","version":"1.0","url":"https://uneyama.hatenadiary.jp/entry/20160829/p13","published":"2016-08-29 00:00:12","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Funeyama.hatenadiary.jp%2Fentry%2F20160829%2Fp13\" title=\"\u81e8\u5e8a\u8a66\u9a13\u306b\u591a\u69d8\u6027\u3001\u30a4\u30f3\u30af\u30eb\u30fc\u30b8\u30e7\u30f3\u3001\u6709\u610f\u7fa9\u306a\u53c2\u52a0\u3092\u78ba\u4fdd\u3059\u308b\u305f\u3081\u306e\u6226\u7565\uff1a\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7\u306e\u8981\u7d04 - \u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","provider_name":"Hatena Blog","title":"\u81e8\u5e8a\u8a66\u9a13\u306b\u591a\u69d8\u6027\u3001\u30a4\u30f3\u30af\u30eb\u30fc\u30b8\u30e7\u30f3\u3001\u6709\u610f\u7fa9\u306a\u53c2\u52a0\u3092\u78ba\u4fdd\u3059\u308b\u305f\u3081\u306e\u6226\u7565\uff1a\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7\u306e\u8981\u7d04"}